Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
"Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease." Ann Palliat Med
See USP and pharmacopoeial references where applicable
Hypothyroidism and obesity: An intriguing link
MASLD was identified in 65% of patients
IMCIVREE should not be used in people with obesity due to suspected POMC, PCSK1, or LEPR deficiency not confirmed by genetic testing (benign or likely benign result), or other types of obesity not related to POMC, PCSK1, or LEPR deficiency, including obesity associated with other genetic conditions and general obesity
US$ 23.44
US$ 22.49
US$ 27.38
US$ 20.63
US$ 24.23
US$ 20.20
US$ 29.85
US$ 26.52
US$ 22.42
US$ 26.63
US$ 23.00
